MicroRNA

BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis

December 1, 2017

BD Rhapsody™ single cell analysis system (Credit: Becton Dickinson) BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of BD Rhapsody, a platform for single [more...]

miRNA Tools and Services Market – Global Opportunity Analysis and Industry Forecast, 2014-2022

June 18, 2017

miRNA is a set of small, non-coding RNA molecules that regulate gene expression post transcription. These molecules have an impact on a wide range of biological functions such as cell cycle control, stem cell differentiation, immune [more...]

Leti Announces Project to Create Nanotherapy Targeting Inflammatory Bowel Disease

May 18, 2017

Leti, a technology research institute of CEA Tech, today announced a European Union project to develop a nanotherapy targeting the molecules involved in inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis. [more...]

Ultrafast Detection of a Cancer Biomarker Enabled by Innovative Nanobiodevice

April 27, 2017

Researchers have developed a nanobiodevice that can quickly and effectively separate microRNA, short lengths of ribonucleic acid present in bodily fluids, from mixtures of nucleic acids. The nanobiodevice contains a unique array of [more...]

Miroculus Acquires Kapplex to Advance Diagnostics for Complex Diseases

May 9, 2016

Miroculus, a San Francisco-based biotechnology company specializing in microRNA-based diagnostics, today announced an agreement to acquire Toronto-based Kapplex Inc. The Canadian company’s proprietary Digital Microfluidic (DMF) platform [more...]